Pure Global

BIO-RAD, S.A. - Manufacturer ProfileBIO-RAD, S.A.

Explore comprehensive manufacturer profile for BIO-RAD, S.A. through Pure Global AI's free Mexico medical device database. This company manufactures 26 medical devices registered with COFEPRIS across 2 risk classes. Their registration history spans from Mar 01, 2018 to May 27, 2024.

This page provides detailed insights including recent registrations, risk class distribution (Clase I: 23, Clase II: 3), and complete regulatory information from the official Mexico COFEPRIS medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Mexico's complete medical device registry.

Free Manufacturer Profile
Powered by Pure Global AI
26 Devices
2 Risk Classes
BIO-RAD, S.A.
BIO-RAD, S.A.
Manufacturer
26
Total Devices
2
Risk Classes
2018
Earliest
2024
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 COFEPRIS device registrations

INMUNOANÁLISIS DE FLUJO MULTIPLEX PAA LA DETECCIÓN CUALITATIVA DE ANTICUERPOS IGG E IGM DEL VIRUS DE EPSTEIN-BARR: EL ANTIGENO NUCLEAR 1 DEL VIRUS DE EPSTEIN-BARR (EBV NA-1), EL ANTIGENO DE LA CAPSIDE VIRICA DEL VIRUS EPSTEIN-BARR (EBV VCA) Y EL ANTIGENO PRECOZ DIFUSO DEL VIRUS DE EPSTEIN-BARR (EBV-EA-D), ASI COMO ANTICUERPOS DE LA CAPSIDE VIRICA (VCA) DEL VIRUS DE EPSTEIN-BARR (EBV) Y LOS ANTICUERPOS HETEROFILOS EN SUERO HUMANO.

INMUNOANÁLISIS DE FLUJO MULTIPLEX PAA LA DETECCIÓN CUALITATIVA DE ANTICUERPOS IGG E IGM DEL VIRUS DE EPSTEIN-BARR: EL ANTIGENO NUCLEAR 1 DEL VIRUS DE EPSTEIN-BARR (EBV NA-1), EL ANTIGENO DE LA CAPSIDE VIRICA DEL VIRUS EPSTEIN-BARR (EBV VCA) Y EL ANTIGENO PRECOZ DIFUSO DEL VIRUS DE EPSTEIN-BARR (EBV-EA-D), ASI COMO ANTICUERPOS DE LA CAPSIDE VIRICA (VCA) DEL VIRUS DE EPSTEIN-BARR (EBV) Y LOS ANTICUERPOS HETEROFILOS EN SUERO HUMANO.

1555R2024 SSA

Clase II
May 27, 2024

SUERO CONTROL HUMANO VALORADO PARA HORMONA ANTIMÜLLERIANA (AMH)

SUERO CONTROL HUMANO VALORADO PARA HORMONA ANTIMÜLLERIANA (AMH)

1080R2024 SSA

Clase I
Apr 16, 2024

SISTEMAS DE PCR EN TIEMPO REAL

SISTEMAS DE PCR EN TIEMPO REAL

0665E2024 SSA

Clase I
Mar 07, 2024

SISTEMA DE PCR EN TIEMPO REAL

SISTEMA DE PCR EN TIEMPO REAL

0303E2024 SSA

Clase I
Jan 29, 2024

SISTEMA CFX 96™ DX

SISTEMA CFX 96™ DX

899E2021 SSA

Clase I
May 26, 2021

CFX96TM DX SYSTEM

CFX96TM DX SYSTEM

136E2021 SSA

Clase I
Feb 04, 2021

ANTI-IGM.

ANTI-IGM.

1808R2019 SSA

Clase II
Sep 03, 2019

LIQUICHEKTM DIABETES CONTROL. LEVELS 1, 2 AND 3.

LIQUICHEKTM DIABETES CONTROL. LEVELS 1, 2 AND 3.

1586R2019 SSA

Clase I
Aug 09, 2019

CANDISELECT™.

CANDISELECT™.

1546R2019 SSA

Clase I
Aug 05, 2019

D-10TM HEMOGLOBIN A1C PROGRAM

D-10TM HEMOGLOBIN A1C PROGRAM

898R2019 SSA

Clase II
May 02, 2019

ID-TITRATION SOLUTION

ID-TITRATION SOLUTION

565R2019 SSA

Clase I
Mar 20, 2019

AUTOINMUNE EIA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES (ASCA) IGA E IGG

AUTOINMUNE EIA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES (ASCA) IGA E IGG

554R2019 SSA

Clase I
Mar 15, 2019

LIQUICHECK TM URINE CHEMISTRY CONTROL.

LIQUICHECK TM URINE CHEMISTRY CONTROL.

545R2019 SSA

Clase I
Mar 15, 2019

D-100™ HEMOGLOBIN TESTING SYSTEM

D-100™ HEMOGLOBIN TESTING SYSTEM

2031E2018 SSA

Clase I
Aug 16, 2018

QUANTASE™ NEONATAL BIOTINIDASE DEFICIENCY SCREENING (BLOOD SPOT CONTROLS).

QUANTASE™ NEONATAL BIOTINIDASE DEFICIENCY SCREENING (BLOOD SPOT CONTROLS).

1435R2018 SSA

Clase I
Jun 07, 2018

QUANTASETM NEONATAL G6PD DEFICIENCY SCREENING (BLOOD SPOT CONTROLS)

QUANTASETM NEONATAL G6PD DEFICIENCY SCREENING (BLOOD SPOT CONTROLS)

1439R2018 SSA

Clase I
Jun 07, 2018

QUANTASETM NEONATAL PHENYLALANINE & TOTAL GALACTOSE SCREENING (BLOOD SPOT STANDARDS & CONTROLS)

QUANTASETM NEONATAL PHENYLALANINE & TOTAL GALACTOSE SCREENING (BLOOD SPOT STANDARDS & CONTROLS)

1229R2018 SSA

Clase I
May 30, 2018

LYPHOCHEK ENDOCRINE CONTROL

LYPHOCHEK ENDOCRINE CONTROL

1207R2018 SSA

Clase I
May 28, 2018

LIQUICHEK™ URINE TOXICOLOGY CONTROL

LIQUICHEK™ URINE TOXICOLOGY CONTROL

1173R2018 SSA

Clase I
May 23, 2018

DAT IGG-DILUTION

DAT IGG-DILUTION

1139R2018 SSA

Clase I
May 17, 2018
Risk Class Distribution
Devices by risk class
Clase I
23
88.5% of total
Clase II
3
11.5% of total